Vaccine manufacturer Indian Immunologicals and Griffith University in Australia have partnered to develop a potential vaccine candidate against Covid-19.
The partners intend to create a live attenuated vaccine using codon de-optimisation technology, which would offer longer protection with a single dose.
In a statement, Indian Immunologicals said: “The technology looks promising for developing a vaccine for prophylactic, active, single-dose immunisation against coronavirus in humans, with an enhanced safety profile. “The vaccine is expected to provide long-lasting protection with a single dose administration with an anticipated safety profile similar to other licensed vaccines for active immunisation.” After research completion, the